|
|
|
Issue Open Date
|
01-Sep-25
|
|
|
|
Issue Closing Date
|
03-Sep-25
|
|
|
|
Application Money
|
100
|
|
|
|
Allotment Money
|
|
|
|
|
|
|
|
Price Band
|
120
-
126
|
|
|
|
Minimium Application No.
|
119
|
|
|
|
Issue Size (Shares)
|
7000000
|
|
|
|
Market Lot
|
1
|
|
|
|
|
|
Objective
|
|
1. Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat;2. Funding capital expenditure requirements towards purchase of equipment, plant and machinery for setting up new manufacturing line for Small Volume Parenteral (“SVP”) at Hariyala, Kheda, Gujarat; and3. General corporate purposes.
|
|
|
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
|
Offered / Reserved |
Bid For |
|
|
Non-Institutional Investors
|
1500000
|
314135486
|
209.423657333333
|
|
Qualified Institutional Buyers
|
2000000
|
71722490
|
35.861245
|
|
Retail Individual Investors
|
3500000
|
192422762
|
54.977932
|
|
|
|
|
Business Description
We are a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterileliquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal (“ABFS”)and Injection Strech Blow Moulding (“ISBM”) technology. Parenteral products can be useful in cases wherepatients cannot intake drug through oral route or drugs are not suitable for oral intake. Additionally, these productsallow rapid absorption of the drug, thereby providing fast action. Furthermore, parenteral routes are better suitedfor drugs which have poor absorption in the gastrointestinal tract or are destroyed by digestive secretions. (Source:CRISIL Report) We manufacture large volume parenterals (“LVPs”) and small volume parenterals (“SVPs”) insix therapeutic segments. In addition to that, we also manufacturer medical devices. We manufacture fluid therapy- (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segmentand products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. We offer wide rangeof closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume rangingfrom 2ml to 1000 ml.
|
|
|
Promoter's Holding
|
|
|
|
Total Share Capital
|
17738828
|
|
|
|
Offered to Public
|
7000000
|
|
|
|
Promoter's Holding (Pre-Issue)
|
61.53
|
|
|
|
Promoter's Holding (Post-Issue)
|
|
|
|
|
|
|
|
|
|
|
|
Address |
8th Floor
Shaligram Corporates
C. J. Marg
Ambli
Ahmedabad,
Gujarat,
380058
Phone : 079-67777600
Email : cs@amanta.co.in
Website : www.amanta.co.in
|
|
|
Registrar |
MUFG Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai
|
|
|
Listed at |
|
BSE, NSE
|
|
|
Lead Manager |
|
Beeline Capital Advisors Pvt Ltd.
|
|
|
Promoters |
Bhavesh Patel
Jayshreeben Patel
Jitendrakumar Patel
Milcent Appliances Pvt Ltd.
Vishal Patel
|
|
